HYDERABAD, India – Smaller domestic and regional pharmaceutical and biotech companies are expanding their footprint in Asia while using the region as a launch pad to emerge as significant global players and to tap a growing ecosystem of biotech-related business. Many of those companies are in India, where policy initiatives and plenty of unmet needs have come together to encourage investment in the space.